Healthcare -
Biotechnology - NASDAQ - US
$ 560.93
-7.47 %
$ 59.5 B
Market Cap
14.19
P/E
REGN - TOTAL ASSETS
Total Assets REGN - Regeneron Pharmaceuticals, Inc.
37.8 B
LAST VALUE
13.69%
2 YEAR CAGR
20.59%
5 YEAR CAGR
25.58%
10 YEAR CAGR